Wird geladen...
Antibody-drug conjugates: Intellectual property considerations
Antibody-drug conjugates are highly complex entities that combine an antibody, a linker and a toxin. This complexity makes them demanding both technically and from a regulatory point of view, and difficult to deal with in their patent aspects. This article discusses different issues of patent protec...
Gespeichert in:
| Veröffentlicht in: | MAbs |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966491/ https://ncbi.nlm.nih.gov/pubmed/26292154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1082019 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|